HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indoline-3-propionate and 3-aminopropyl carbamates reduce lung injury and pro-inflammatory cytokines induced in mice by LPS.

AbstractBACKGROUND AND PURPOSE:
In the search for safer and effective anti-inflammatory agents, we investigated the effect of methyl indoline-3-propionate and indoline-3-(3-aminopropyl) carbamates on LPS-induced lung injury and pro-inflammatory cytokines in mice. Their mechanism of action was determined in murine peritoneal macrophages.
EXPERIMENTAL APPROACH:
Lung injury was induced by intratracheal infusion of LPS and assessed by the change in lung weight and structure by light microscopy after staining by haematoxylin and eosin. In LPS-activated macrophages, MAPK proteins and IκBα were measured by Western blotting and the transcription factors, AP-1 and NF-κB by electromobility shift assay. Cytokines in the plasma and spleen of mice injected with LPS were measured by elisa-based assay.
KEY RESULTS:
AN917 and AN680 (1-10 pM) decreased TNF-α protein in macrophages by inhibiting phosphorylation of p38 MAPK, IκBα degradation and activation of AP-1 and NF-κB without affecting cell viability. In vivo, these compounds (10 μmol · kg(-1)) markedly decreased lung injury induced by LPS and the elevation of TNF-α and IL-6 in lung, plasma and spleen. Activation of α-7nACh receptors contributed to the reduction of TNF-α by AN917, which inhibited AChE in the spleen by 35%.
CONCLUSION AND IMPLICATIONS:
Indoline carbamates are potent inhibitors of pro-inflammatory mediators in murine macrophages and in mice injected with LPS, acting via the p38 MAPK, AP-1 and NF-κB cascades. Indirect α-7nACh receptor activation by AN917, through inhibition of AChE, contributes to its anti-inflammatory effect. Indoline carbamates may have therapeutic potential for lung injury and other diseases associated with chronic inflammation without causing immunosuppression.
AuthorsE Finkin-Groner, D Moradov, H Shifrin, C Bejar, A Nudelman, M Weinstock
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 172 Issue 4 Pg. 1101-13 (Feb 2015) ISSN: 1476-5381 [Electronic] England
PMID25322956 (Publication Type: Journal Article)
Copyright© 2014 The British Pharmacological Society.
Chemical References
  • Carbamates
  • Cytokines
  • Indoles
  • Lipopolysaccharides
  • Receptors, Nicotinic
  • Cholinesterases
Topics
  • Acute Lung Injury (drug therapy, immunology)
  • Animals
  • Carbamates (pharmacology, therapeutic use)
  • Cell Line
  • Cells, Cultured
  • Cholinesterases (metabolism)
  • Cytokines (immunology)
  • Female
  • Indoles (pharmacology, therapeutic use)
  • Lipopolysaccharides
  • Macrophages, Peritoneal (drug effects, immunology)
  • Male
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Receptors, Nicotinic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: